CAR-T SOFTWARE

EDITLife
Advanced Cell and Gene Therapies

EDITLife’s Cell Therapy module empowers is an end-to-end data management solution designed to help centers maintain compliance, improve efficiency, and enhance patient outcomes. It supports a wide range of advanced therapies – including CAR-T, other IECTs, and Gene Therapy – providing the tools teams need to manage complex treatments with confidence and consistently deliver the highest-quality products patients rely on. 

This scalable module captures the complete product lifecycle, providing clear visibility into every patient journey — from referral through long-term follow-up.

Trusted by leading cell therapy clinics, the module delivers the robust, automated tools teams need to provide safer, more effective Advanced Therapies.

Complete Support for Advanced Therapies

Designed to streamline CAR-T management, the module:

  • Supports autologous and allogeneic treatments.
  • Allows centers to receive and manage CAR-T products.
  • Enables centers to create unlimited sub-categories for products such as Abecma, Breyanzi, Carvykti, and more.

Optimized for IECT management, the module:

  • Supports autologous and allogeneic therapies.
  • Allows centers to receive and manage a variety of IECT products.
  • Enables centers to create unlimited sub-categories for products such as Tumor Infiltrating Lymphocytes (TILs), Amtagvi, NK cells, and more.
Designed to simplify gene therapy workflows, the module enables centers to:
  • Receive and manage diverse gene therapy products.
  • Document and track patient-specific protocols.
  • Create unlimited sub-categories for products such as Lyfgenia, Zynteglo, Casgevy, and more.

Powerful Pre-CAR-T Infusion Tools

Innovative and automated features and functionality designed to enhance the CAR-T pre-infusion workflow, including the Co-Morbidity Index, Selection Conference tool, and the HCT Scheduler and Calendar

Interconnected Product Collection and Processing Suite

A series of interconnected screens that “talk” to each other – data entered on one screen is auto-updated in the appropriate fields in screens throughout the application.

Innovative Post-CAR-T Infusion Features

EDITLife enhances your ability to monitor the ever-expanding group of CAR-T patients’ outcomes post-infusion and to comply with FDA standards.
The system provides the tools needed for following patients for the FDA-required period of 15 years to assess the risk of development of subsequent neoplasms and other potential adverse effects.
 
INDICATION STATUS

Track primary indication Status post-infusion for patient care and reporting.

Auto-generated summary of the primary indication displays Treatments and Procedures as well as Status information (First Remission, Second Remission, Relapse, etc.)

TOXICITY ASSESSMENT

Monitor and manage the unique toxicities associated with CAR-T therapy.

Streamlined methodology for capturing and summarizing Assessment and Treatment data for adverse events, including Cytokine Release Syndrome (CRS) and Neurotoxicity.

PRODUCT PERSISTENCE

Evaluate the persistence of CAR-T cells post-infusion.

Track the evaluation method (Molecular Assay, Flow Cytometry, Immunohistochemistry, Other), cell source, and infused cell detection over time.

 

CIBMTR

Everything you need for CIBMTR CAR-T forms in one place

  • Alerts you of forms due and due dates for each patient and for groups of patients

  • Validates forms and provides user-friendly messages for correcting errors

  • Links take you directly to fields with missing data

  • Provides a Forms History along with Form Status

 

Auto-populate and electronically submit CAR-T forms supported by CIBMTR for electronic submission

The EDITLife team works closely with CIBMTR to validate and verify the electronic submission of newly created CAR-T forms and HCT forms modified to also collect CAR-T data.

Check out EDITLife today!

See for yourself how EDITLife tracks CAR-T patient outcomes and simplifies CIBMTR CAR-T form reporting.